Circulating ghrelin crosses the blood-cerebrospinal fluid barrier via growth hormone secretagogue receptor dependent and independent mechanisms
Introduction
Ghrelin is an acylated peptide hormone secreted from enteroendocrine cells of the gastrointestinal tract (Kojima et al., 1999). Ghrelin acts via a G-protein coupled receptor, named the growth hormone secretagogue receptor (GHSR), which is highly expressed in the pituitary and the brain (Howard et al., 1996). A main target of ghrelin is the central nervous system, where ghrelin regulates growth hormone secretion, food intake, blood glucose homeostasis and stress responses, among other functions (Yanagi et al., 2018). Since no physiologically relevant levels of ghrelin are synthesized in the brain (Cabral et al., 2017b), plasma ghrelin needs to be transported into the brain in order to gain access to its neuronal targets. Ghrelin-responsive neurons are widely distributed in a number of well-characterized brain nuclei; however, the accessibility of plasma ghrelin to most of these targets is strikingly low (Cabral et al, 2013, 2015; Perello et al., 2019; Schaeffer et al., 2013).
In order to gain access to the brain, ghrelin could either cross the blood-brain barrier, diffuse through the fenestrated capillaries at circumventricular organs (CVOs) or cross the blood-cerebrospinal fluid (CSF) barrier (Perello et al., 2019). The transport of mouse ghrelin across the blood-brain barrier in a blood-to-brain direction appears to be very low under normal conditions (Banks, 2002). Plasma ghrelin passively extravasates from the fenestrated capillaries of the CVOs, such as the hypothalamic median eminence (ME) and the area postrema (AP) (Cabral et al, 2014, 2017a; 2014; Schaeffer et al., 2013). However, this entry pathway for circulating ghrelin limits its action to GHSR-expressing neurons located nearby fenestrated capillaries, such as the ventromedial region of the arcuate nucleus (ARH), which contains fenestrated capillaries that branch from the hypophyseal system, or the AP itself (Cabral et al, 2014, 2017a; 2014; Ciofi, 2011; Schaeffer et al., 2013). Notably, recent evidence showed that plasma ghrelin is also selectively transported across the blood-CSF barrier and reaches the CSF (Uriarte et al., 2018). Since the monolayer of ependymal cells that line the brain ventricles displays a variable level of permeability (Mullier et al., 2010; Smith et al., 2004), CSF ghrelin can diffuse to the periventricular brain parenchyma and reach some populations of GHSR-expressing neurons that are not reached by plasma ghrelin. Thus, the blood-CSF barrier appears to play a key role for the central actions of ghrelin.
The blood-CSF barrier is formed by the choroid plexus epithelial (CPE) cells and the hypothalamic β-type tanycytes (Banks, 2019; Prevot et al., 2018). The CPE cells form a layer of cuboidal cells that surrounds a core of fenestrated capillaries in the brain ventricles and produce CSF. The β-type tanycytes are specialized bipolar ependymal cells that line the floor of the third ventricle and bridge the CSF with the fenestrated capillaries of the ME. Little is known about the mechanisms by which cells of the blood-CSF barrier transport circulating ghrelin into the CSF (Perello et al., 2019). The blood-CSF barrier does not allow the free diffusion of plasma ghrelin into the CSF, as indicated by the fact that CSF ghrelin levels are significantly smaller than plasma ghrelin levels. In sheep, CSF ghrelin levels show a pulsatile profile, with around half of the peaks in the CSF preceded by peaks in plasma, and systemically-injected ghrelin increases CSF ghrelin levels around 40–50 min after treatment (Grouselle et al., 2008). In mice, CSF ghrelin levels also increase after systemic administration of the hormone, and such elevation seems to be important for the full orexigenic action of the systemically-injected hormone since ghrelin-induced food intake is partially reduced by immuno-neutralization of ghrelin in the CSF (Uriarte et al., 2018). At cellular level, systemically-injected fluorescent ghrelin is internalized by CPE cells and by hypothalamic tanycytes in mice (Cabral et al., 2014; Schaeffer et al., 2013; Uriarte et al., 2018). Fluorescent ghrelin is also rapidly internalized by rat tanycytes in vitro, and this tanycytic ghrelin shuttle likely plays a role in the postnatal ARH development (Collden et al., 2015). Currently, the mechanisms transporting ghrelin through the blood-CSF barrier are uncertain. Given the potent effects of ghrelin treatment in several species, including humans, it seems very likely that this hormone (or ghrelin-mimetic compounds) would be used to treat patients suffering a variety of disorders, such as loss of appetite or weight loss. Thus, gaining insights into the mechanisms that transport ghrelin into the brain is a major aspect of the biology of ghrelin that may have clinical implications. Here, we performed a variety of in vivo and in vitro studies to test the hypothesis that the transport of ghrelin across the blood-CSF barrier in adult mice occurs in a GHSR-dependent manner.
Section snippets
Animals
Mice used in this study were generated in the animal facility of either the IMBICE, La Plata, the University of Lille, or Aarhus University, Aarhus. Experimental mice included: 1) C57BL/6 WT mice, 2) GHSR-deficient mice, which do not express the GHSR (Zigman et al., 2006), and 3) Ai14 mice (Allen Institute, 129S6-Gt (ROSA)26Sortm14(CAGtdTomato)Hze/J; Stock# 007908), which harbor a targeted mutation of the Gt (ROSA)26Sor locus with a loxP-flanked STOP cassette preventing the transcription of the
Fluorescent signal was reduced in the CPE cells of GHSR-deficient mice ICV-injected with Fr-ghrelin
In order to test if the internalization of ghrelin in the blood-CSF barrier requires GHSR, we analyzed the presence of fluorescent signal in the choroid plexus and the hypothalamic tanycytes of adult WT and GHSR-deficient mice that had been ICV-injected with Fr-ghrelin. In WT mice, Fr-ghrelin was found internalized in some cells of the choroid plexus of the lateral, dorsal third and four ventricles as well as in most β-type tanycytes, which extend processes into the ME or the ventral ARH, and
Discussion
In a previous study, we reported that systemically injected ghrelin is internalized in cells of the blood-CSF barrier and then intactly transported to the CSF, from where it reaches the periventricular brain parenchyma (Uriarte et al., 2018). Now, we expand our findings and show that the transport of plasma ghrelin through the blood-CSF barrier in adult mice mainly depends on the presence of GHSR, but to a lesser extent might also occur in a GHSR-independent manner. Additionally, we found that
CRediT authorship contribution statement
Maia Uriarte: Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft. Pablo N. De Francesco: Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft. Gimena Fernández: Data curation, Formal analysis, Investigation, Methodology. Daniel Castrogiovanni: Investigation, Methodology. Micaela D'Arcangelo: Investigation, Methodology. Mónica Imbernon: Data curation, Formal analysis, Methodology. Sonia Cantel:
Acknowledgements
We would like to thank to Dr. Jeff Zigman (UTSW, Dallas, USA) for providing the GHSR-deficient mice, and to Christian V. Westberg, Dr. Guadalupe García-Romero and Lic. Mirta Reynaldo for their technical assistance. We also thank Nathalie Jouy (cell sorting core facility) from the BioImaging Center of Lille (BiCeL), and Julien Devassine (animal core facility) of the UMS2014-US41 for expert technical support. This work was supported by grants from the Fondo para la Investigación Científica y
References (52)
- et al.
Hypothalamic tanycytes are an ERK-gated conduit for leptin into the brain
Cell Metabol.
(2014) - et al.
Development of a novel fluorescent ligand of growth hormone secretagogue receptor based on the N-Terminal Leap2 region
Mol. Cell. Endocrinol.
(2019) - et al.
Analysis of brain nuclei accessible to ghrelin present in the cerebrospinal fluid
Neuroscience
(2013) The arcuate nucleus as a circumventricular organ in the mouse
Neurosci. Lett.
(2011)- et al.
Neonatal overnutrition causes early alterations in the central response to peripheral ghrelin
Mol Metab
(2015) - et al.
Tanycytic VEGF-A boosts blood-hypothalamus barrier plasticity and access of metabolic signals to the arcuate nucleus in response to fasting
Cell Metabol.
(2013) - et al.
Why study transport of peptides and proteins at the neurovascular interface
Brain Res. Brain Res. Rev.
(2004) - et al.
Ghrelin transport across the blood-brain barrier can occur independently of the growth hormone secretagogue receptor
Mol Metab
(2018) - et al.
Peptide and peptide analog transport systems at the blood-CSF barrier
Adv. Drug Deliv. Rev.
(2004) - et al.
The homeostatic force of ghrelin
Cell Metabol.
(2018)
Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite
J. Clin. Invest.
Health-related quality of life and psychological distress among cancer survivors in Southeast Asia: results from a longitudinal study in eight low- and middle-income countries
BMC Med.
The blood-brain barrier as an endocrine tissue
Nat. Rev. Endocrinol.
Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure
J. Pharmacol. Exp. Therapeut.
Circulating ghrelin acts on GABA neurons of the area postrema and mediates gastric emptying in male mice
Endocrinology
Brain circuits mediating the orexigenic action of peripheral ghrelin: narrow gates for a vast kingdom
Front. Endocrinol.
Is ghrelin synthesized in the central nervous system?
Int. J. Mol. Sci.
Ghrelin indirectly activates hypophysiotropic CRF neurons in rodents
PloS One
Divergent neuronal circuitries underlying acute orexigenic effects of peripheral or central ghrelin: critical role of brain accessibility
J. Neuroendocrinol.
A decade's progress in the development of molecular imaging agents targeting the growth hormone secretagogue receptor
Mol. Imag.
Ghrelin recruits specific subsets of dopamine and GABA neurons of different ventral tegmental area sub-nuclei
Neuroscience
The ups and downs of growth hormone secretagogue receptor signaling
FEBS J.
A cellular and spatial map of the choroid plexus across brain ventricles and ages
Cell
A simple strategy for culturing morphologically-conserved rat hypothalamic tanycytes
Cell Tissue Res.
Leptin brain entry via a tanycytic LepR-EGFR shuttle controls lipid metabolism and pancreas function
Nat Metab
Evidence supporting a role for constitutive ghrelin receptor signaling in fasting-induced hyperphagia in male mice
Endocrinology
Cited by (18)
Ghrelin/GHSR signaling in the lateral septum ameliorates chronic stress-induced depressive-like behaviors
2024, Progress in Neuro-Psychopharmacology and Biological PsychiatryHow gut hormones shape reward: A systematic review of the role of ghrelin and GLP-1 in human fMRI
2023, Physiology and BehaviorGhrelin receptor signaling in health and disease: a biased view
2023, Trends in Endocrinology and MetabolismCitation Excerpt :Accordingly, GHSR1a in the hypothalamus and brain stem can be activated locally by circulating ghrelin via direct entry through proximal fenestrated capillaries, thereby enabling rapid and dynamic responsiveness to changes in energy demand. Additionally, acyl-ghrelin can traverse the blood–cerebrospinal fluid (CSF) barrier via hypothalamic tanycyte uptake [46], albeit with low efficiency. Conversely, GHSR1a-expressing regions protected by the BBB may mediate ghrelin-independent effects on a distinct timescale and/or become accessible only when energy balance is significantly perturbed.
Design and characterization of a triazole-based growth hormone secretagogue receptor modulator inhibiting the glucoregulatory and feeding actions of ghrelin
2022, Biochemical PharmacologyCitation Excerpt :We confirmed that rat/mouse ghrelin (60 nmol/kg) from these two providers displayed equivalent orexigenic activity as assessed two hours after subcutaneous administration in mice. The synthesis and characterization of the fluorescent ghrelin variant (GSD(octanoylamide)FLSPEHQRVQQRKESC-(DY-647P)) (hereafter named ghrelin(1–18)DY) were previously reported [42]. The reference inverse agonist of GHSR developed by Els et al K-(D-1-Nal)-FwLL-NH2 [29] was also synthesized at the IBMM, Montpellier France.
An insight into the multifunctional role of ghrelin and structure activity relationship studies of ghrelin receptor ligands with clinical trials
2022, European Journal of Medicinal ChemistryCitation Excerpt :Ghrelin may exhibit both endocrine and paracrine effects because it is expressed in many organs like the stomach, heart [8,9], lungs, ovaries [10], kidney, testis [11], pancreas [12], duodenum, jejunum, ileum, colon [8], pituitary, and hypothalamus [13]. Recent research has well explained ghrelin and its receptor functions and also effects of other elements on it [14–26]. Ghrelin has two major forms: the acylated form (n-octanoylated) and unacylated (nonoctanoylated) form, and 20% of ghrelin is spotted as octanoylated at the amino acid-3 [27,28].
- 1
equal contribution.